COPD

A smart mobile health tool that supports patients with chronic obstructive pulmonary disease (COPD) may be an effective alternative to a paper action plan for self-management of exacerbations.

Two recent abstracts presented at the European Respiratory Society International Congress investigated the decision-making and care management for chronic obstructive pulmonary disease (COPD) patients.

Enrollment in a high-deductible health plan was shown to be associated with cost-related barriers to care, financial strain, and more frequent emergency department (ED) visits and hospitalizations for patients with chronic obstructive pulmonary disease (COPD), according to a study.

Enrollment in a high-deductible health plan was shown to be associated with cost-related barriers to care, financial strain, and more frequent emergency department (ED) visits and hospitalizations for patients with chronic obstructive pulmonary disease (COPD), according to a study.

JAMA on Tuesday retracted and republished a 2018 study about chronic obstructive pulmonary disease (COPD) after the discovery of a programming error in the statistical analysis. The subsequent complete reanalysis by the authors showed that the intervention that was studied showed harm, rather than benefit, to patients.

Use of wrist-worn step trackers were shown to accurately estimate exercise capacity and determine the health status of patients with COPD and cardiovascular diseases, based off research presented at the 2019 European Respiratory Society Congress.

Researchers have proposed a new tool and framework involving a personalized approach for managing chronic obstructive pulmonary disease (COPD) and the use of inhaled corticosteroids.

Patients with severe persistent asthma or severe COPD, with additional inclinations toward anxiety or panic disorders, exhibited an increased interest in using digital inhalers, based off 2 Health Union condition-specific surveys.

A recent study investigating the cardiovascular contribution to COPD symptoms and their relationship to a patient's diagnostic status found that patients with suspicious echocardiographic findings were undiagnosed and untreated.

Older adults above the age of 66 with COPD were found to be twice as likely to use prescription synthetic oral cannabinoids when compared with adults of the same age without COPD, according to a study.

Patients who reported feeling lonely had worse health ratings, 6-minute walk tests, and breathlessness.

A link between a genetic risk score (GRS) related to chronic obstructive pulmonary disease (COPD) susceptibility and computed tomagraphy (CT) lung structure was found, indicating the possible use of lung structure data to determine COPD risk, according to a new study.

Home initiation of chronic noninvasive ventilation in patients with chronic obstructive pulmonary disease (COPD) with chronic hypercapnic respiratory failure was shown to be as safe as in-hospital initiation, and reduced costs by more than 50%, according to a new study.

Albert Rizzo, MD, FACP, chief medical officer for the American Lung Association, discusses the prevalence of overtreatment and undertreatment in chronic obstructive pulmonary disease (COPD).

A total of 45% of patients made at least 1 error when using an inhaler, and the number of errors per patient ranged from 1 to 6.

Men without chronic obstructive pulmonary disease (COPD) showed an associated difference in bone quality based on their smoking status and pack-years, according to a new study.

Patients with lower neutrophil counts had similar reductions in pneumonia, regardless of whether their treatment contained or did not contain inhaled corticosteroids.

The findings, coming from data on more than 900 patients with chronic obstructive pulmonary disease, indicate that as depression severity increased, so did the odds of landing in the hospital.

Chronic obstructive pulmonary disease (COPD) is understood to be linked with both physical and mental distress, and recent research also suggests that, among current and former smokers with COPD, there exists a significant unmet need in terms of patients’ anxiety and depressive symptoms.

Albert Rizzo, MD, FACP, chief medical officer for the American Lung Association, discusses the use of forced expiratory volume in 1 second (FEV1) /forced vital capacity (FVC) for the diagnosis of chronic obstructive pulmonary disease.

While pulmonary rehabilitation (PR) is an evidence-based and cost-effective treatment for people with chronic obstructive pulmonary disease (COPD), uptake of and compliance with this intervention has been poor. For patients who decline PR, inspiratory muscle training (IMT), which involves strengthening the inspiratory muscles by increasing their workload, may be an option, particularly as it can be performed in the home instead of in a clinic.

While air pollution has long been associated with cardiovascular and respiratory diseases, this is believed to be the first longitudinal study of air pollution and emphysema progression.

The clinical features of systemic inflammation in chronic obstructive pulmonary disease (COPD) are well recognized, but little is understood about the molecular mechanisms underlying this inflammation.

The study of more than 21,000 patients showed that after a median follow-up of 2.1 years, patients with comorbid chronic obstructive pulmonary disease (COPD) had significantly worse overall survival and progression-free survival.

Using bronchodilators early on in patients with chronic obstructive pulmonary disease (COPD) is increasingly understood to be an important therapeutic intervention to improve quality of life, inhibit disease progression, and allow for greater physical activity. One recent paper sought to compare 2 treatment options with respect to their impact on pulmonary function, health-related quality of life, and physical activity: twice-daily inhalation therapy with aclidinium and once-daily inhalation therapy with tiotropium.

Chronic kidney disease comorbid with chronic obstructive pulmonary disease (COPD) was associated with increased mortality, independent of other cardiovascular comorbidities.

A recent study used a cross-sectional analysis of a large cohort of patients with atrial fibrillation (AF) to investigate the relationship between chronic obstructive pulmonary disease (COPD) and AF to identify mediators of increased vascular risk; they found that the risk of cardiovascular complications is higher for patients with AF who also have COPD than it is for patients without COPD.

The prevalence of chronic obstructive pulmonary disease (COPD) was nearly 50% higher among patients with arthritis compared with those without arthritis, even after adjusting for sociodemographic characteristics, risk behaviors, frequent distress, and asthma status.

In a study recently published in Respirology, investigators sought to identify the benefit of using a handheld flow meter in screening patients for chronic obstructive pulmonary disease (COPD).

Researchers from the United Kingdom found that the C-reactive protein (CRP) finger-prick blood test resulted in significantly fewer people using antibiotics for chronic obstructive pulmonary disease (COPD) flare-ups without negatively affecting patient health.